ClinicalTrials.Veeva

Menu

Perfluorooctyl Bromide Which Empowers the Liquid to Flat the Detached Retina and Displace the Underneath Fluids Anteriorly

E

EL Romany Ophthalmics

Status

Enrolling

Conditions

Retinal Disease

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

Perfluorohexyloctaneis Essential for Repositioning Giant Retinal Breaks and Can be Used for Removal of Subretinal Fluid as Well as Stabilization of the Retina to Offset

Enrollment

20 estimated patients

Sex

All

Ages

20 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    • Is 20 years or older Has been diagnosed with Keratoconus; Has no other active ocular disease; Is not pregnant or nursing;

Exclusion criteria

  • Is under the age of 20 Has best corrected visual acuity outside 20/400; Pregnant or nursing at the time of enrollment in the study;

Trial design

20 participants in 1 patient group

eye surgery ,Vitreoretinal Surgery and Related Ocular Inflammation

Trial contacts and locations

1

Loading...

Central trial contact

El R Ophthalmics

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems